Pune: A woman (51) was given a new lease of life after city doctors successfully removed a rare 18-kg uterine tumour – one of the largest tumours reported in recent times.To put things in perspective, the size of the tumour is equivalent to 6 fully grown healthy foetuses.The complex and high-risk case was led by Dr Nikhil Parwate, Gynae Oncology & Robotic Surgeon at Aditya Birla Memorial Hospital (ABMH). He said, “The patient was suffering from severe abnormal menstrual bleeding for nearly 2 months, forcing her to change around 12 sanitary pads daily. She also complained of abdominal bloating, dizziness, palpitations and extreme fatigue. By the time she sought medical attention, her haemoglobin level dropped to a critical low of 5 g/dL, leaving her extremely pale and weak.“Albeit the tumour was massive, surgeons were able to remove it entirely in one piece through an open surgery. Remarkably, the blood loss was less than 100 ml, and the patient did not require any blood transfusion during or after the procedure. The surgery was performed on Nov 12 and by Nov 16 she was discharged.Commenting on the case, Dr Parwate said, “This was a highly challenging case because of the sheer size of the uterine tumour and the patient’s compromised health condition. Through meticulous pre-operative planning, careful blood management and precision surgery, we were able to safely remove the entire mass without damaging surrounding organs. Early diagnosis and timely intervention play a critical role in achieving such successful outcomes.“The tumour was suspected to be cancerous prior to the surgery based on the imaging findings. After the surgery and hysterectomy, however, the histopathology report stated that the tumour was not malignant.Dr Rajesh Badani, Interventional Cardiologist & Electrophysiologist at ABMH, said, “The patient had an asymptomatic increase in the size of the uterus that reached huge proportions in a short span of time. However, with close cardiac supervision and a coordinated team approach, we were able to safely support her through this extremely high-risk surgery. During her last follow-up in Dec, the patient was completely recovered.“Pamesh Gupta, CEO of ABMH, said, “Specialists from gynaec oncology, cardiology, anesthesiology, urology, pathology and critical care came together as an integrated team. Such cross-specialty collaboration is critical in managing complex, high-risk cases, where timely decision-making and collective expertise can be life-saving. It also reinforces the importance of early detection and prompt intervention in ensuring the best possible outcomes for patients.”
